AHRI.Optimised electronic patient records to improve clinical monitoring of HIV-positive patients in rural South Africa (MONART Trial) 27 March 2020 to 30 June 2024
South Africa, 2023 - 2024
Get Microdata
Reference ID
AHRI.MONART.MainStudy.2024.v1
Producer(s)
Iwuji Collins
Metadata
Created on
Oct 18, 2024
Last modified
Oct 18, 2024
Page views
1786
Downloads
35
- Data files
- AHRI.MONART.MainStudy.2024.v1
ART treatment code in Chart (dqc_art_code_chart)
Data file: AHRI.MONART.MainStudy.2024.v1
Overview
Valid:
3606
Invalid:
594
Type:
Discrete
Decimal:
0
Width:
67
Range:
1 - 95
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | TDF (Tenofovir)+3TC (Lamuvidine)+DTG (Dolutegravir) = 1T30 | 3459 |
95.9%
|
| 2 | TDF( Tenofovir)+3TC (Lamuvidine)+EFV (Efavirenz) = 1T3E | 46 |
1.3%
|
| 3 | TDF (Tenofovir)+FTC (Emtricitabine)+EFV (Efavirenz) = 1TFE | 42 |
1.2%
|
| 4 | AZT (Zidovudine)+3TC (Lamuvidine)+EFV (Efavirenz) = 1Z3E | 5 |
0.1%
|
| 5 | ABC (Abacavir)+3TC (Lamuvidine)+EFV (Efavirenz) = 1A3E | 4 |
0.1%
|
| 6 | AZT (Zidovudine)+3TC (Lamuvidine)+LPV/r (Lopinavir/Ritonavir)= 1Z3L | 11 |
0.3%
|
| 7 | ABC (Abacavir)+3TC (Lamuvidine)+LPV/r (Lopinavir/Ritonavir)= 1Z3L | 2 |
0.1%
|
| 95 | Other | 37 |
1%
|
| Sysmiss | 594 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.